BIOSYNTEX Trademark

Trademark Overview

On Saturday, May 21, 2022, a trademark application was filed for BIOSYNTEX with the United States Patent and Trademark Office. The USPTO has given the BIOSYNTEX trademark a serial number of 97422601. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Monday, January 12, 2026. This trademark is owned by BioSyntex Laboratories, LLC. The BIOSYNTEX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for medical and scientific research use; pharmaceutical preparations for scientific research; investigational pharmaceutical preparations for clinical and preclinical research use; synthetic peptides for medical use; biological compounds for pharmaceutical research use; drug delivery agents for delivery of pharmaceutical preparations; drug delivery agents in the nature of nanoparticles, liposomes or vesicles for pharmaceutical use; injectable pharmaceutical preparations for research use; transdermal pharmaceutical preparations for research use; implantable pharmaceutical preparations for research use; controlled-release pharmaceutical preparations for research use; pharmaceutical preparations for use in drug discovery and development; pharmaceutical preparations for use in translational medical research; all of the foregoing excluding dietary supplements, nutraceuticals, vitamins, mineral supplements, probiotic preparations, and consumer wellness products.
biosyntex

General Information

Serial Number97422601
Word MarkBIOSYNTEX
Filing DateSaturday, May 21, 2022
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateMonday, January 12, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for medical and scientific research use; pharmaceutical preparations for scientific research; investigational pharmaceutical preparations for clinical and preclinical research use; synthetic peptides for medical use; biological compounds for pharmaceutical research use; drug delivery agents for delivery of pharmaceutical preparations; drug delivery agents in the nature of nanoparticles, liposomes or vesicles for pharmaceutical use; injectable pharmaceutical preparations for research use; transdermal pharmaceutical preparations for research use; implantable pharmaceutical preparations for research use; controlled-release pharmaceutical preparations for research use; pharmaceutical preparations for use in drug discovery and development; pharmaceutical preparations for use in translational medical research; all of the foregoing excluding dietary supplements, nutraceuticals, vitamins, mineral supplements, probiotic preparations, and consumer wellness products.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 26, 2022
Primary Code005
First Use Anywhere DateThursday, August 4, 2022
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBioSyntex Laboratories, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressOro Valley, AZ 85755

Trademark Events

Event DateEvent Description
Wednesday, May 25, 2022NEW APPLICATION ENTERED
Thursday, May 26, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 23, 2023ASSIGNED TO EXAMINER
Wednesday, March 8, 2023NON-FINAL ACTION WRITTEN
Wednesday, March 8, 2023NON-FINAL ACTION E-MAILED
Wednesday, March 8, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 12, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, July 12, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, July 13, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, September 14, 2023TEAS PETITION TO REVIVE RECEIVED
Thursday, September 14, 2023PETITION TO REVIVE-GRANTED
Thursday, September 14, 2023NOTICE OF REVIVAL - E-MAILED
Thursday, September 14, 2023NOTICE OF REVIVAL - E-MAILED
Thursday, September 14, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 6, 2024ASSIGNED TO LIE
Tuesday, February 6, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 6, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 29, 2024NON-FINAL ACTION WRITTEN
Thursday, February 29, 2024NON-FINAL ACTION E-MAILED
Thursday, February 29, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 29, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, May 29, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, August 29, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 29, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 29, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 29, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 29, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 29, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 24, 2024SUSPENSION LETTER WRITTEN
Thursday, October 24, 2024LETTER OF SUSPENSION E-MAILED
Thursday, October 24, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, April 25, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, September 16, 2025ASSIGNED TO EXAMINER
Monday, December 29, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, January 9, 2026TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, January 12, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 12, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 30, 2026TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, January 30, 2026PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

Related Keywords

biosyntex pharmaceutical preparations research medical drug delivery agents supplements scientific dietary